PIEZO1 and neoplasm: Concurrently, the Piezo1–CXCL12/CXCR4 axis recruits myeloid cells (e.g., monocytes, MDSCs) and may indirectly impair CD8+ T-cell function by remodeling the tumor milieu (118, 119).